BIT 5.00% 1.9¢ biotron limited

The point wasn't to compare BIT225 with a full blown 96 Week...

  1. 177 Posts.
    The point wasn't to compare BIT225 with a full blown 96 Week Trial with 300+ patients. It was "out of interest this is what will have to be done eventually"
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.